December 2010 Seminar

Diagnostic Identifiers and Biologic Behavior Contrasted in Adult Versus Pediatric Neoplasms
Drs. Pedram Argani and Juan Rosai

Sunday, December 5, 2010
8:30AM to 4:30 PM

Hyatt Regency Hotel
5 Embarcadero Center
San Francisco, CA
(415) 788-1234‎


View Larger Map

Pedram (“Pete”) Argani, MD is Professor of Pathology and Oncology and Director of the Breast Pathology Progam at John Hopkins University and Hospital in Baltimore, MD. After graduating Summa Cum Laude in molecular biology at Princeton, Dr. Argani graduated medical school at the University of Pennsylvania where he also did pathology residency followed by two fellowships at Memorial-Sloan Kettering Cancer Center in New York. He has over 130 published papers in peer-reviewed journals and has established himself as an international leader in surgical pathology, molecular studies breast and GU pathology. He has been on over 25 manuscript review boards and has written 14 book chapters. Honors have included numerous teaching awards and the 2007 Arthur Purdy Stout Prize.

Over the past several decades, Juan Rosai, MD, has been perhaps the most influential leader of surgical pathology. He is currently head of the Pathology Consultation Centre at the Centro Diagnostico Italiano, Milan, Italy and Senior Diagnostic Pathologist at Genzyme Corp., New York. He received his MD degree from the University of Buenos Aires, Argentina and in 1967, completed his postgraduate training in Pathology at Barnes Hospital and Washington University (St. Louis). Affiliations/professorships have included Washington University (St. Louis), the University of Minnesota, Yale University, Memorial Sloan-Kettering Cancer Center, adjunct professor at Cornell University, and professor at the National Cancer Institute in Milan. His book editorships have included several AFIP fascicles, the WHO book on Histologic Classification of Thymic Tumors, and Rosai and Ackerman’s Surgical Pathology, currently in its ninth edition. In addition, he is the author of approximately 300 publications which include original articles, reviews and essays. He has received Doctor Honoris Causa Degrees from the University of Bologna (Italy), the University of Santiago de Compostela (Spain), the University of Ioannina (Greece) and the University of Cordoba (Argentina). He has also been awarded the Honorary Fellowship of the Royal College of Pathologists (England) and the Maude Abbott Lectureship of the US and Canadian Academy of Pathology. Additionally, Dr. Rosai has described several new tumor entities and other diseases, one of which bears his name (Rosai-Dorfman disease).

Objectives: At the conclusion of the seminar the participants will have been updated on the behavioral differences of pediatric and adult neoplasms, and will have a better grasp of new diagnostic modalities and how they augment traditional diagnostic methods.

June 2010 Seminar

Surgical Pathology of Important Clinical Endocrine Disorders
Lester D.R. Thompson, M.D.

Sunday, June 6, 2010
8:30-4:30 PM

Westin Hotel South Coast Plaza
686 Anton Blvd
Costa Mesa, CA 92626
(714)540-2500; Fax (714)662-6695


View Larger Map

Dr. Lester D.R. Thompson is currently a consultant and general pathologist with Southern California Permanente Medical Group in Woodland Hills.  He graduated summa cum laude from Columbia Union College (Maryland).  He obtained his medical degree and and orthopedic surgery internship at Loma Linda University Medical Center.  He completed a pathology residency at UCLA, with an emphasis in cytopathology.  He worked at the Armed Forces Institute of Pathology serving as Chief of the Otorhinolaryngic Head & Neck Division of the Department of Endocrine and Otorhinolaryngic-Head and Neck Department, and served as Chief of immunohistochemistry division.  He also worked as a Cytopathologist for Walter Reed Army Medical Center.  He has published 48 book chapters and has well over 200 publications, mostly in the fields of endocrine or head and neck pathology.

December 2009 Seminar

The Diagnosis of Bone Tumors Using an Imaging-Based Approach:  A Way to Diminish Apprehension
Michael J. Klein, M.D.

Sunday, December 6, 2009
8:30AM-4:30PM

The Hyatt Embarcadero Hotel
5 Embarcadero Center
San Francisco, CA 94111
(415) 433-3717


View Larger Map

Dr. Michael J. Klein is currently Director of Pathology and Laboratory Medicine at the Hospital for Special Surgery, New York.  He graduated from Temple University School of Medicine, did his pathology residency at New York University Medical Center, with a fellowship in orthopedic pathology at NYU and at Columbia University.  He was Associate Director of Laboratories at the Hospital for Joint Diseases Orthopaedic Institute in New York before becoming a Professor of Pathology and Orthopaedics at the Mount Sinai School of Medicine.  He has numerous awards for teaching merit from Mount Sinai and has received awards from the Radiological Society of North America, the International Skeletal Society and others.  His publications are in excess of 160, and he has been published in numerous lay magazines such as Discover, Omni, Geo and others.  His photography has graced 8 magazine covers, and he has won or placed in 18 photographic competitions.  Dr. Klein has written 13 book chapters, as well as three books, including the AFIP Fascicle on Non-neoplastic Disorders of Bone and Joints (1st Series).

June 2009 Seminar

Hematologic Disorders
Lawrence Weiss, M.D.

June 7, 2009
8:30 a.m. – 4:30 p.m.

Westin Hotel South Coast Plaza
686 Anton Boulevard
Costa Mesa, CA 92626
(714)540-2500; Fax (714)662-6695


View Larger Map

At the conclusion of this seminar, attendees will have up-to-date criteria for diagnosing neoplasms of the hematolymphoid system, both within lymph nodes and at extranodal sites. The proper use of ancillary studies will be illustrated, and the importance of the integration of morphologic, immunohistochemical, and molecular data will be stressed. They will know how to apply the 2001 WHO system to accurately classify these neoplasms. In addition, they will be made aware of recent advances in our understanding of hematolymphoid neoplasms.

Scroll to top